Fuso Pharmaceutical Industries,Ltd. (4538.T)
JPY 2388.0
(0.55%)
JPY 2388.0
(0.55%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.37 Billion JPY | -14.21% |
| 2022 | 1.6 Billion JPY | 8.23% |
| 2021 | 1.48 Billion JPY | -7.72% |
| 2020 | 1.6 Billion JPY | 127.3% |
| 2019 | 707 Million JPY | -20.92% |
| 2018 | 894 Million JPY | -7.84% |
| 2017 | 970 Million JPY | 12.66% |
| 2016 | 861 Million JPY | 8510.0% |
| 2015 | 10 Million JPY | -97.06% |
| 2014 | 340 Million JPY | -82.82% |
| 2013 | 1.97 Billion JPY | -59.37% |
| 2012 | 4.87 Billion JPY | 1209.41% |
| 2011 | 372 Million JPY | -67.48% |
| 2010 | 1.14 Billion JPY | 120.85% |
| 2009 | 518 Million JPY | 155.64% |
| 2008 | -931 Million JPY | -970.09% |
| 2007 | 107 Million JPY | 105.25% |
| 2006 | -2.03 Billion JPY | -5.65% |
| 2005 | -1.92 Billion JPY | -431.44% |
| 2004 | 582 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 632 Million JPY | 321.33% |
| 2023 Q2 | 238 Million JPY | -50.31% |
| 2023 Q1 | 479 Million JPY | 327.68% |
| 2023 Q4 | 150 Million JPY | -70.59% |
| 2023 FY | 1.37 Billion JPY | -14.21% |
| 2023 Q3 | 510 Million JPY | 114.29% |
| 2022 Q2 | 459 Million JPY | -17.89% |
| 2022 Q4 | 112 Million JPY | -76.42% |
| 2022 Q1 | 559 Million JPY | 4758.33% |
| 2022 Q3 | 475 Million JPY | 3.49% |
| 2022 FY | 1.6 Billion JPY | 8.23% |
| 2021 Q4 | -12 Million JPY | -102.65% |
| 2021 FY | 1.48 Billion JPY | -7.72% |
| 2021 Q3 | 452 Million JPY | -8.87% |
| 2021 Q1 | 547 Million JPY | 968.25% |
| 2021 Q2 | 496 Million JPY | -9.32% |
| 2020 Q4 | -63 Million JPY | -116.71% |
| 2020 Q1 | 721 Million JPY | 8111.11% |
| 2020 Q2 | 572 Million JPY | -20.67% |
| 2020 FY | 1.6 Billion JPY | 127.3% |
| 2020 Q3 | 377 Million JPY | -34.09% |
| 2019 FY | 707 Million JPY | -20.92% |
| 2019 Q4 | -9 Million JPY | -103.18% |
| 2019 Q2 | 23 Million JPY | -94.39% |
| 2019 Q1 | 410 Million JPY | 1852.38% |
| 2019 Q3 | 283 Million JPY | 1130.43% |
| 2018 Q3 | 381 Million JPY | 48.25% |
| 2018 FY | 894 Million JPY | -7.84% |
| 2018 Q1 | 235 Million JPY | 770.37% |
| 2018 Q2 | 257 Million JPY | 9.36% |
| 2018 Q4 | 21 Million JPY | -94.49% |
| 2017 Q1 | 192 Million JPY | 292.0% |
| 2017 FY | 970 Million JPY | 12.66% |
| 2017 Q3 | 678 Million JPY | 828.77% |
| 2017 Q2 | 73 Million JPY | -61.98% |
| 2017 Q4 | 27 Million JPY | -96.02% |
| 2016 Q1 | 287 Million JPY | 195.67% |
| 2016 FY | 861 Million JPY | 8510.0% |
| 2016 Q4 | -100 Million JPY | -118.02% |
| 2016 Q3 | 555 Million JPY | 366.39% |
| 2016 Q2 | 119 Million JPY | -58.54% |
| 2015 FY | 10 Million JPY | -97.06% |
| 2015 Q4 | -300 Million JPY | -247.06% |
| 2015 Q3 | 204 Million JPY | 265.85% |
| 2015 Q2 | -123 Million JPY | -153.71% |
| 2015 Q1 | 229 Million JPY | 243.13% |
| 2014 Q3 | 300 Million JPY | 289.61% |
| 2014 Q4 | -160 Million JPY | -153.33% |
| 2014 FY | 340 Million JPY | -82.82% |
| 2014 Q1 | 123 Million JPY | -53.23% |
| 2014 Q2 | 77 Million JPY | -37.4% |
| 2013 Q2 | 428 Million JPY | -33.23% |
| 2013 Q4 | 263 Million JPY | -59.35% |
| 2013 FY | 1.97 Billion JPY | -59.37% |
| 2013 Q1 | 641 Million JPY | 76.58% |
| 2013 Q3 | 647 Million JPY | 51.17% |
| 2012 Q3 | 3.18 Billion JPY | 407.01% |
| 2012 Q4 | 363 Million JPY | -88.6% |
| 2012 Q1 | 696 Million JPY | 321.82% |
| 2012 FY | 4.87 Billion JPY | 1209.41% |
| 2012 Q2 | 628 Million JPY | -9.77% |
| 2011 Q1 | -226 Million JPY | -2925.0% |
| 2011 Q2 | 163 Million JPY | 172.12% |
| 2011 Q3 | 270 Million JPY | 65.64% |
| 2011 Q4 | 165 Million JPY | -38.89% |
| 2011 FY | 372 Million JPY | -67.48% |
| 2010 Q3 | 658 Million JPY | -0.3% |
| 2010 Q2 | 660 Million JPY | 464.64% |
| 2010 FY | 1.14 Billion JPY | 120.85% |
| 2010 Q4 | 8 Million JPY | -98.78% |
| 2010 Q1 | -181 Million JPY | -118.25% |
| 2009 Q1 | -511 Million JPY | 43.47% |
| 2009 Q4 | 992 Million JPY | 853.85% |
| 2009 Q3 | 104 Million JPY | 255.22% |
| 2009 Q2 | -67 Million JPY | 86.89% |
| 2009 FY | 518 Million JPY | 155.64% |
| 2008 Q2 | -173 Million JPY | 0.0% |
| 2008 FY | -931 Million JPY | -970.09% |
| 2008 Q4 | -904 Million JPY | -658.02% |
| 2008 Q3 | 162 Million JPY | 193.64% |
| 2007 FY | 107 Million JPY | 105.25% |
| 2006 FY | -2.03 Billion JPY | -5.65% |
| 2005 FY | -1.92 Billion JPY | -431.44% |
| 2004 FY | 582 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | 57.036% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 99.044% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 100.437% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 99.15% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -1163.778% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 94.673% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 82.841% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 96.753% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -97.561% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 90.142% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | 69.716% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 865.0% |
| Tsumura & Co. | 16.7 Billion JPY | 91.758% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 87.661% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | 66.57% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 91.486% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | 59.913% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 82.189% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | 74.126% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 128.136% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | 58.209% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 170.154% |
| MedRx Co., Ltd | -932 Million JPY | 247.747% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | 63.516% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 223.831% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 157.571% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 81.75% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 89.945% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 333.702% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 93.334% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | 53.264% |